48 results
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
on that product, the manufacturing facility or us, including requiring recall or withdrawal of the product from the market or suspension of manufacturing
POS AM
SYRE
Spyre Therapeutics Inc.
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
, including requiring recall or withdrawal of the product from the market or suspension of manufacturing. restrictions on our ability to conduct clinical
POS AM
SYRE
Spyre Therapeutics Inc.
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
, the manufacturing facility or us, including requiring recall or withdrawal of the product from the market or suspension of manufacturing. restrictions on our ability
PRER14A
1ddpu budg1ei0yxspbr
6 Oct 23
Preliminary revised proxy
9:40pm